1. Home
  2. ATPC vs NSRX Comparison

ATPC vs NSRX Comparison

Compare ATPC & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agape ATP Corporation

ATPC

Agape ATP Corporation

N/A

Current Price

$1.23

Market Cap

63.0M

Sector

Health Care

ML Signal

N/A

NSRX

Nasus Pharma Ltd. Ordinary Shares

N/A

Current Price

$6.80

Market Cap

63.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ATPC
NSRX
Founded
2016
2019
Country
Malaysia
Israel
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.0M
63.4M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
ATPC
NSRX
Price
$1.23
$6.80
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$22.00
AVG Volume (30 Days)
33.4K
3.0K
Earning Date
11-13-2025
12-19-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,484,905.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
9.66
N/A
52 Week Low
$0.90
$5.90
52 Week High
$2.93
$9.99

Technical Indicators

Market Signals
Indicator
ATPC
NSRX
Relative Strength Index (RSI) 45.59 N/A
Support Level $1.21 N/A
Resistance Level $1.38 N/A
Average True Range (ATR) 0.07 0.00
MACD -0.01 0.00
Stochastic Oscillator 18.52 0.00

Price Performance

Historical Comparison
ATPC
NSRX

About ATPC Agape ATP Corporation

Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs. Its segments include: Skin care, health and wellness segment includes the provision of health and wellness products and health solution advisory services; and Green energy segment includes providing renewable energy products, technical solutions, installations and maintenance services. It derives maximum revenue from Skin care, health and wellness segment.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: